What are the treatment options for herpes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Herpes

For herpes simplex virus infections, the first-line treatment is oral antiviral therapy with valacyclovir, acyclovir, or famciclovir, with specific regimens depending on the type of infection (genital, labial) and whether it's an initial episode, recurrent episode, or suppressive therapy. 1

Types of Herpes and First-Line Treatments

Herpes Simplex (HSV-1 and HSV-2)

  • Oral/Labial Herpes (Cold Sores):

    • First episode or recurrent episode:
      • Valacyclovir: 2 grams twice daily for 1 day 2
      • Famciclovir: 1500 mg as a single dose 3
      • Acyclovir: 800 mg five times daily for 5 days 1
  • Genital Herpes:

    • Initial episode:

      • Valacyclovir: 1 gram twice daily for 10 days 2
      • Acyclovir: 800 mg five times daily for 7-10 days 1
      • Famciclovir: Not FDA approved for first episodes 3
    • Recurrent episodes:

      • Valacyclovir: 500 mg twice daily for 3-5 days 2
      • Famciclovir: 1000 mg twice daily for 1 day 3
      • Acyclovir: 800 mg five times daily for 5 days 1
    • Suppressive therapy:

      • Valacyclovir: 1 gram once daily (for ≥10 recurrences/year) or 500 mg once daily (for <10 recurrences/year) 2, 4
      • Famciclovir: 250 mg twice daily 3
      • Acyclovir: 800 mg twice daily 1

Herpes Zoster (Shingles)

  • Valacyclovir: 1 gram three times daily for 7 days 1
  • Famciclovir: 500 mg every 8 hours for 7 days 3
  • Acyclovir: 800 mg five times daily for 7-10 days 1

Comparative Efficacy

  • Valacyclovir appears somewhat more effective than famciclovir for suppression of genital herpes and viral shedding 5
  • For herpes zoster, valacyclovir is more effective than acyclovir in reducing pain and postherpetic neuralgia 6
  • Valacyclovir is the only antiviral FDA-approved for once-daily suppressive therapy for genital herpes and for a 3-day regimen of episodic treatment 6

Special Populations

HIV-Infected Patients

  • Recurrent orolabial or genital herpes:
    • Famciclovir: 500 mg twice daily for 7 days 3
    • Valacyclovir: 500 mg twice daily for 5-10 days 1, 2

Renal Impairment

  • Dosage adjustments required based on creatinine clearance:

    Acyclovir (800 mg dose):

    Creatinine Clearance (mL/min) Dose Adjustment
    >25 800 mg every 4 hours, 5x daily
    10-25 800 mg every 8 hours
    0-10 800 mg every 12 hours

    Valacyclovir:

    Creatinine Clearance (mL/min) Dose Adjustment
    ≥50 No adjustment needed
    30-49 No adjustment needed
    10-29 500 mg every 24 hours
    <10 500 mg every 24 hours

Adjunctive Treatments for Symptom Management

  • Pain management:
    • Topical anesthetics (e.g., lidocaine 2% for oral lesions)
    • Oral analgesics following WHO pain management ladder
    • Sitz baths with warm water for genital lesions
    • Keeping lesions clean and dry 1

Prevention of Transmission

  • Suppressive antiviral therapy reduces the risk of HSV transmission to sexual partners 2
  • Patients should abstain from sexual activity while lesions are present
  • Condom use during all sexual exposures is recommended
  • Patients should be educated about asymptomatic viral shedding 1

Important Clinical Considerations

  • Treatment efficacy is maximized when started within 48-72 hours of symptom onset 1
  • Suppressive therapy reduces recurrence frequency by 70-80% 1
  • For pregnant women with genital herpes, healthcare providers should be informed 1
  • Elderly patients may require dose adjustment due to age-related changes in renal function 1

Valacyclovir and famciclovir have better bioavailability and less frequent dosing requirements than acyclovir, which may improve patient adherence to therapy 6, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.